Systemic allergic contact dermatitis due to ethylenediamine following administration of oral aminophylline

British Journal of Dermatology

Volumn 150, Issue 3, 2004, Pages 594-

  Walker, S L ^a   Ferguson, J E ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BETAMETHASONE; CARBOCISTEINE; CETIRIZINE; ETHYLENEDIAMINE; TRIAMCINOLONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; PATCH TEST; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN ALLERGY;

ADMINISTRATION, ORAL; AGED; AMINOPHYLLINE; DERMATITIS, ALLERGIC CONTACT; DERMATOLOGIC AGENTS; ETHYLENEDIAMINES; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS;

EID: 1842454263     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05796.x     Document Type: Article

References (7)

1. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary 44, September 2002; 142.
2. Baer RL, Cohen HJ, Neidorff AH. Allergic eczematous sensitivity to aminophylline. Arch Dermatol 1959; 79: 647-8.
3. Guin JD, Fields P, Thomas KL. Baboon syndrome from iv aminophylline in a patient allergic to ethylenediamine. Contact Dermatitis 1999; 40: 170-1.
4. Petrozzi JW, Shore RN. Generalized exfoliative dermatitis from ethylenediamine. Arch Dermatol 1976; 112: 525-6.
5. Urbani CE. Urticarial reaction to ethylenediamine in aminophylline following mesotherapy. Contact Dermatitis 1994; 31: 198-9.
6. Bernstein JE, Lorincz AL. Ethylenediamine-induced exfoliative erythroderma. Arch Dermatol 1979; 115: 360-1.
7. Stingeni LE, Caraffini S, Agostinelli D et al. Maculopapular and urticarial eruption from cetirizine. Contact Dermatitis 1997; 37: 249-50.